CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL	B-cell acute lymphoblastic leukemia, B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease	Active, not recruiting	Phase 2	2026-09-02		NCT05470777

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Nantong University	71
Jiangsu Province Natural Science Foundation of China (Grant No. BK20210091)	1
Jining Medical University	15
National Natural Science Foundation of China	35
Northern Jiangsu People's Hospital	51
Suzhou Hospital of Traditional Chinese Medicine	9
The First Affiliated Hospital of Bengbu Medical University	47
The First Affiliated Hospital of Soochow University	164
The Second People's Hospital of Huai'an	14

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Soochow University	Suzhou	China	101